[Clinical problems in Medical Mycology: Problem number 56]

Rev Iberoam Micol. 2023 Apr-Jul;40(2-3):35-38. doi: 10.1016/j.riam.2022.12.001. Epub 2023 Nov 15.
[Article in Spanish]

Abstract

We present the case of a twenty six year-old woman with rheumatoid arthritis, treated with certolizumab. She sought medical attention due to cough, fever and night sweats. X-ray exam showed a miliary pneumonia. She was treated for tuberculosis and 50days later she presented with aphasia. Magnetic nuclear resonance revealed brain lesions. Histoplasma capsulatum PCR test and urinary antigen were positive, so an antifungal treatment with voriconazole was started. Visual adverse effects forced to change the antifungal schedule in both the length of treatment and the antifungal drug. With this measure the patient progressed favorably. The test of urinary Histoplasma capsulatum antigen and PCR amplification were key to make a diagnosis and also for a follow-up.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Antifungal Agents* / pharmacology
  • Antifungal Agents* / therapeutic use
  • Female
  • Histoplasma
  • Histoplasmosis* / complications
  • Histoplasmosis* / diagnosis
  • Histoplasmosis* / drug therapy
  • Humans
  • Mycology
  • Voriconazole / pharmacology

Substances

  • Antifungal Agents
  • Voriconazole